Ending Neglected Tropical Diseases (NTDs) will help people around the world to thrive. Alongside our partners, we have been working to prevent and treat these diseases for many years. Since 2000, Lymphatic Filariasis has been eliminated in 17 countries and over 925 million people have received treatment. GSK is committed to doing more - working together in global partnerships to provide access and develop infrastructure in affected countries to ensure that hundreds of thousands of people around the world get the treatment they need.
